Table 4.
Inorganic NMs can be exploited to modulate or suppress inflammation in autoimmunity.
| Immune Setting | Inorganic NM | Effect | Ref. |
|---|---|---|---|
| Autoimmunity | AuNPs | Antigen and adjuvant delivery induced tolerance is models of MS and T1D |
152 158 |
| Peptide coating reduced disease severity in inflammatory bowel disease model |
165 166 |
||
| Iron oxide NPs | Display of self-antigen in MHCs induced tolerance in models of T1D, MS, and arthritis. TREG expansion depended on dose and ligand density. |
167 168 169 |
|
| Inhibited TH1 cytokine expression in cells and reduced immune cell infiltration in a delayed-type hypersensitivity model |
172 174 |
||
| QDs | Efficacy in a model of MS was dependent on self-antigen ligand dose and density | 180 |